⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5590814 | 0.69 | — | — | |
| SCHEMBL7125447 | 0.67 | — | — | |
| SCHEMBL9541224 | 0.62 | — | — | |
| SCHEMBL4476192 | 0.61 | — | — | |
| SCHEMBL232975 | 0.59 | — | — | |
| SCHEMBL4529080 | 0.58 | ALDH1A1 (0.31) | — | |
| SCHEMBL371007 | 0.56 | — | — | |
| SCHEMBL28824417 | 0.56 | — | — | |
| SCHEMBL2166929 | 0.56 | — | — | |
| SCHEMBL8679082 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257056-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-08-14 | — | — | US | disclosed |
| US-12319672-B2 | Alpha-D-galactopyranoside derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-03 | — | — | US | disclosed |
| CN-115803351-B | Weakened mixed catalyst | 陶氏环球技术有限责任公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-115515991-B | Attenuated post-metallocene catalysts | 陶氏环球技术有限责任公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-115698102-B | Attenuated post-metallocene catalysts | 陶氏环球技术有限责任公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-114585619-B | Alpha-D-galactopyranoside derivatives | 爱杜西亚药品有限公司 | 2024-09-27 | — | — | CN | disclosed |
| EP-4021904-B1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-01-03 | — | — | EP | disclosed |
| US-20220281855-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-09-08 | — | — | US | disclosed |
| EP-4021904-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | Idorsia Pharmaceuticals Ltd (CH) | 2022-07-06 | — | — | EP | disclosed |
| WO-2021038068-A1 | ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-03-04 | — | — | WO | disclosed |
| US-9951291-B2 | Producing carbon-based boundary films from catalytically active lubricant additives | UCHICAGO ARGONNE, LLC (US) | 2018-04-24 | — | — | US | disclosed |
| US-20160340602-A1 | PRODUCING CARBON-BASED BOUNDARY FILMS FROM CATALYTICALLY ACTIVE LUBRICANT ADDITIVES | UCHICAGO ARGONNE, LLC (US) | 2016-11-24 | — | — | US | disclosed |
| CN-105503595-A | Preparation method of R-type methyl 2-methyl-hexyl-4-acetylenate | BIOCOMPOUNDS PHARMACEUTICAL INC | 2016-04-20 | — | — | CN | disclosed |
| US-20130052524-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC DEVICE | SONY CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
| US-7632550-B2 | Film forming method employing reactive and reducing gases and substrate formed by the method | KONICA CORPORATION (JP) | 2009-12-15 | — | — | US | disclosed |
| US-7312235-B2 | Benzamide inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| EP-1373194-B1 | BENZAMIDE INHIBITORS OF FACTOR Xa | MILLENNIUM PHARM INC (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1373194-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | Millennium Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20030069250-A1 | Benzamide inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. | 2003-04-10 | — | — | US | disclosed |
| WO-2002079145-A1 | BENZAMIDE INHIBITORS OF FACTOR Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | WO | disclosed |